Results 231 to 240 of about 7,593,003 (291)

Publishing the History of Radical Science in a Time of Digital Capitalism

Berichte zur Wissenschaftsgeschichte, EarlyView.
This paper investigates publishing as a practice in the history of science. It firstly provides an experiential account of building a DIY‐inspired publishing venue for collective, source‐based narration. The venue used the possibilities of digital publishing to apply, rather than simply refer to, a very striking aspect of radical science in the 1970s ...
Niki Rhyner
wiley   +1 more source

Real-time PEM fuel cell fault classification in smart manufacturing plant by using uncertainty aware federated deep learning. [PDF]

Sci Rep
Aurangzeb M, Shusheng X, Iqbal S, Shafiullah M, Qazi HS, Dafalla AM, Fuguang Z, Zhuoyu L, Xinwei L, Nazir S.   +9 more
europepmc   +1 more source

Affinity Peptides With pH Sensitivity for the Enrichment of CD38+ Cells

Biotechnology and Bioengineering, EarlyView.
ABSTRACT The selective enrichment of cell populations based on surface markers is critical for the advancement of gene and cell therapies. Current antibody‐based cell isolation methods, such as fluorescence‐ and magnetic‐activated cell sorting (FACS and MACS), offer high specificity but are limited by scalability, cost, and potential adverse effects on
Gabrielle Rusch, Mickael Meyer, I. Mohamed Irfan, Carson Huber, Joseph Burclaff, Scott T. Magness, Stefano Menegatti, Michael Daniele   +7 more
wiley   +1 more source

Active Learning Under Expert-Budget Constraints: A Human-in-the-Loop Pipeline for Diabetic Retinopathy Lesion Detection. [PDF]

Bioengineering (Basel)
Kim H, Chang SM, Lim BY, Lee SY, Jung HG.   +4 more
europepmc   +1 more source

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

Biotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga, Udisha Singh, Sachin Dattram Pawar   +2 more
wiley   +1 more source

A physiologically constrained calibration framework for cardiovascular models applied to a paediatric synthetic sepsis population. [PDF]

PLoS Comput Biol
Cabeleira MT, Ray S, Ovenden NC, Díaz-Zuccarini V.   +3 more
europepmc   +1 more source

Obstacle-aware inverse kinematics of variable-length continuum robots via teaching-learning-based optimization with experimental validation. [PDF]

Sci Rep
Ghoul A, Sattar AM, Adoul MA, Sadki O, Djeffal S.   +4 more
europepmc   +1 more source

Enhancing knowledge graph recommendations through deep reinforcement learning. [PDF]

Sci Rep
Zhou J, Shen D, Guo Y, Zhao Y, Zhang H.
europepmc   +1 more source

Gaugefixer: overcoming parameter non-identifiability in models of sequence-function relationships. [PDF]

BMC Bioinformatics
Martí-Gómez C, McCandlish DM, Kinney JB.   +2 more
europepmc   +1 more source

Power distribution system blackstart restoration using renewable energy. [PDF]

Nat Commun
Shi W, Bai C, Wang Z.
europepmc   +1 more source